FirstWord

FirstWord is a company belonging to one of the most colossal global healthcare knowledge networks. The company offers its customers a wealthy collection of reports covering various sectors of the worldwide pharmaceutical market and, thereby, providing them with unparalleled knowledge to get a leg up on other competitors in the sphere.

Prepared using the rich and reliable information sources, FirstWord’s reports grant access to the unrivalled quantitative and qualitative intelligence on the pharmaceutical industry; offer insightful market analyses; clearly describe predominant development trends; characterize the foremost factors having an effect on the market; and discuss the most burning issues having relation to the specific industry.

Research Reports By FirstWord

Found 212 publications
Diabetes - KOL Insight and Consensus Outlook Modules US$ 7,495.00 Feb, 2014 224 pages
Designing Clinical Trials to Show Value US$ 495.00 Jan, 2014 63 pages
Marketing Collection US$ 6,495.00 Oct, 2013
Market Access Collection US$ 4,095.00 Oct, 2013
Emerging Markets Collection US$ 3,295.00 Oct, 2013
Generics/Biosimilars Collection US$ 4,595.00 Oct, 2013
Medical Affairs Collection US$ 2,295.00 Oct, 2013
Colorectal Cancer - KOL Insight Module US$ 4,995.00 Oct, 2013 127 pages
Strategies for Working With Real World Data US$ 395.00 Oct, 2013 61 pages
Multiple Sclerosis: KOL Insight US$ 4,995.00 Sep, 2013 148 pages
1 2 3 4 5
Skip to top

News & Press-Releases by FirstWord